We serve Chemical Name:5-amino-3-ethyl-4-Isoxazole carboxamide CAS:35261-07-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-amino-3-ethyl-4-Isoxazole carboxamide
CAS.NO:35261-07-5
Synonyms:5-Amino-3-ethyl-1,2-oxazole-4-carboxamide;5-amino-3-ethyl-4-Isoxazole carboxamide;4-Isoxazolecarboxamide, 5-amino-3-ethyl-;5-Amino-3-aethylisoxazol-4-carboxamid;5-amino-3-ethyl-isoxazole-4-carboxylic acid amide
Molecular Formula:C6H9N3O2
Molecular Weight:155.155
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:314.4±42.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.574
PSA:95.14000
Exact Mass:155.069473
LogP:0.04
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Amino-3-ethyl-1,2-oxazole-4-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-amino-3-ethyl-isoxazole-4-carboxylic acid amide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-3-ethyl-1,2-oxazole-4-carboxamide Use and application,4-Isoxazolecarboxamide, 5-amino-3-ethyl- technical grade,usp/ep/jp grade.
Related News: Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 5-amino-3-ethyl-4-Isoxazole carboxamide manufacturer He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. 5-amino-3-ethyl-4-Isoxazole carboxamide supplier Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 5-amino-3-ethyl-4-Isoxazole carboxamide vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 5-amino-3-ethyl-4-Isoxazole carboxamide factory Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process.
